sellWeak
Fortress Biotech, Inc. sold $129k of CKPT
owner at Checkpoint Therapeutics, Inc.. 100,000 shares at an average of $1.29, traded May 29, 2025, filed Jun 3, 2025.
Warning score
23Value
$129k
100,000 shares
Holdings after
6,122,249
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +11Trade size$129k at market
- 0Share of holdings soldSold 1.6% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-015470, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 29, 2025 | SOpen-market sale COMMON STOCK, PAR VALUE $0.0001 | -100,000 | $1.29 | $129k | 6,122,249 | Jun 3, 2025 |
| May 30, 2025 | DDisposition to issuer COMMON STOCK, PAR VALUE $0.0001 | -6,122,249 | $4.10 | $25M | 0 | Jun 3, 2025 |
| May 30, 2025 | DDisposition to issuer CLASS A COMMON STOCK, PAR VALUE $0.0001derivative | -700,000 | $0.00 | $0 | 0 | Jun 3, 2025 |
Related signals
Other insiders at Checkpoint Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 37Weak | Checkpoint Therapeutics, Inc. | William Garrett Gray Chief Financial Officer | $50k 12,322 shares | -1% | |
| 40Moderate | Checkpoint Therapeutics, Inc. | James F Oliviero III CEO, President and Director | $61k 15,090 shares | -0% | |
| 41Moderate | Checkpoint Therapeutics, Inc. | James F Oliviero III CEO, President and Director | $64k 19,564 shares | -1% | |
| 43Moderate | Checkpoint Therapeutics, Inc. | William Garrett Gray Chief Financial Officer | $272k 74,110 shares | -5% | |
| 60Notable | Checkpoint Therapeutics, Inc. | William Garrett Gray Chief Financial Officer | $1.1M 268,432 shares | -21% | |
| 63Notable | Checkpoint Therapeutics, Inc. | James F Oliviero III CEO, President and Director | $3.1M 822,397 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.